State Street’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-63,743
| Closed | -$26.8K | – | 4355 |
|
|
2024
Q4 | $26.8K | Hold |
63,743
| – | – | ﹤0.01% | 4197 |
|
|
2024
Q3 | $126K | Hold |
63,743
| – | – | ﹤0.01% | 3934 |
|
|
2024
Q2 | $340K | Buy |
+63,743
| New | +$266K | ﹤0.01% | 3659 |
|
|
2023
Q4 | – | Sell |
-565
| Closed | -$12.5K | – | 4518 |
|
|
2023
Q3 | $12.5K | Buy |
565
+436
| +338% | +$11.4K | ﹤0.01% | 4491 |
|
|
2023
Q2 | $913 | Hold |
129
| – | – | ﹤0.01% | 4673 |
|
|
2023
Q1 | $5.95K | Hold |
129
| – | – | ﹤0.01% | 4765 |
|
|
2022
Q4 | $18.4K | Hold |
129
| – | – | ﹤0.01% | 4743 |
|
|
2022
Q3 | $73K | Hold |
129
| – | – | ﹤0.01% | 4567 |
|
|
2022
Q2 | $104K | Hold |
129
| – | – | ﹤0.01% | 4517 |
|
|
2022
Q1 | $339K | Buy |
129
+13
| +11% | +$27.6K | ﹤0.01% | 4196 |
|
|
2021
Q4 | $300K | Hold |
116
| – | – | ﹤0.01% | 4186 |
|
|
2021
Q3 | $531K | Hold |
116
| – | – | ﹤0.01% | 3953 |
|
|
2021
Q2 | $691K | Buy |
116
+93
| +404% | +$600K | ﹤0.01% | 3740 |
|
|
2021
Q1 | $184K | Hold |
23
| – | – | ﹤0.01% | 3855 |
|
|
2020
Q4 | $141K | Buy |
23
+19
| +475% | +$116K | ﹤0.01% | 3788 |
|
|
2020
Q3 | $30K | Hold |
4
| – | – | ﹤0.01% | 3784 |
|
|
2020
Q2 | $28K | Hold |
4
| – | – | ﹤0.01% | 3752 |
|
|
2020
Q1 | $14K | Sell |
4
-8
| -67% | -$33.2K | ﹤0.01% | 3716 |
|
|
2019
Q4 | $69K | Sell |
12
-6
| -33% | -$56.7K | ﹤0.01% | 3702 |
|
|
2019
Q3 | $229K | Hold |
18
| – | – | ﹤0.01% | 3600 |
|
|
2019
Q2 | $148K | Sell |
18
-79
| -81% | -$925K | ﹤0.01% | 3634 |
|
|
2019
Q1 | $1.27M | Buy |
97
+5
| +5% | +$85.1K | ﹤0.01% | 3289 |
|
|
2018
Q4 | $1.39M | Buy |
92
+9
| +11% | +$211K | ﹤0.01% | 3249 |
|
|
2018
Q3 | $3.08M | Buy |
83
+4
| +5% | +$132K | ﹤0.01% | 3084 |
|
|
2018
Q2 | $3.07M | Buy |
79
+74
| +1,480% | +$2.81M | ﹤0.01% | 3084 |
|
|
2018
Q1 | $148K | Buy |
5
+1
| +25% | +$26.9K | ﹤0.01% | 3586 |
|
|
2017
Q4 | $85K | Buy |
4
+1
| +33% | +$20.6K | ﹤0.01% | 3611 |
|
|
2017
Q3 | $62K | Hold |
3
| – | – | ﹤0.01% | 3653 |
|
|
2017
Q2 | $47K | Sell |
3
-48
| -94% | -$962K | ﹤0.01% | 3599 |
|
|
2017
Q1 | $1.33M | Buy |
51
+12
| +31% | +$337K | ﹤0.01% | 3205 |
|
|
2016
Q4 | $1.03M | Buy |
39
+1
| +3% | +$30.8K | ﹤0.01% | 3272 |
|
|
2016
Q3 | $1.37M | Buy |
38
+2
| +6% | +$65.7K | ﹤0.01% | 3109 |
|
|
2016
Q2 | $1.44M | Buy |
36
+17
| +89% | +$767K | ﹤0.01% | 3163 |
|
|
2016
Q1 | $927K | Buy |
19
+4
| +27% | +$177K | ﹤0.01% | 3236 |
|
|
2015
Q4 | $829K | Buy |
15
+3
| +25% | +$162K | ﹤0.01% | 3249 |
|
|
2015
Q3 | $539K | Hold |
12
| – | – | ﹤0.01% | 3320 |
|
|
2015
Q2 | $989K | Hold |
12
| – | – | ﹤0.01% | 3246 |
|
|
2015
Q1 | $947K | Buy |
12
+3
| +33% | +$279K | ﹤0.01% | 3234 |
|
|
2014
Q4 | $879K | Buy |
9
+1
| +13% | +$82.4K | ﹤0.01% | 3291 |
|
|
2014
Q3 | $715K | Buy |
+8
| New | +$744K | ﹤0.01% | 3325 |
|
State Street's TTOO Position: Q1 2025 in Review
State Street sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 63,743 shares — an estimated $26.8K sold.
State Street first reported a position in TTOO in Q3 2014 and held it in 40 quarters. The position peaked at $3.08M in Q3 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- State Street reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- State Street sold 63,743 T2 Biosystems, Inc shares in Q1 2025, an estimated $26.8K.
- State Street first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 40 quarters.
- State Street's T2 Biosystems, Inc position peaked at $3.08M in Q3 2018.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.